Form 4: Sonida Senior Living Executive Max Levy Acquires 85,000 Shares of Common Stock
SEC Form 4 Filing
Max Levy, Senior Vice President and Chief Investment Officer of Sonida Senior Living, acquired a total of 85,000 shares of common stock on June 2, 2024, through restricted stock and performance-based restricted stock grants.
Summary
- On June 2, 2024, Max Levy, Senior Vice President and Chief Investment Officer of Sonida Senior Living, acquired 15,000 shares of restricted stock.
- These shares vest in installments of 33%, 33%, and 34% on June 2, 2025, June 2, 2026, and June 2, 2027, respectively.
- Levy also acquired 15,000 shares of performance-based restricted stock that will vest upon achievement of a target performance objective.
- An additional 55,000 shares of performance-based restricted stock were granted, also vesting upon achievement of a target performance objective.
- Following these transactions, Levy directly owns 85,000 shares of Sonida Senior Living common stock.
Sentiment
Score: 6
Explanation: The document is a routine filing related to executive compensation. It doesn't contain overtly positive or negative information, hence a neutral sentiment score.
Positives
- The acquisition of shares by a key executive could signal confidence in the company's future performance.
- The vesting schedules tied to performance objectives may incentivize strong performance from the executive.
Risks
- The vesting of performance-based restricted stock is contingent on achieving target performance objectives, which may not be met.
Future Outlook
The vesting of the performance-based restricted stock is dependent on the achievement of future performance objectives.
Industry Context
Executive stock grants are a common practice in the senior living industry to align management's interests with those of shareholders.
Stakeholder Impact
- The stock grants could potentially align management's interests with those of shareholders, encouraging value creation.
Key Dates
| Date | Description |
|---|---|
| 06/02/2024 | Date of transaction: Grant of restricted stock and performance-based restricted stock. |
| 06/02/2025 | First vesting date for the restricted stock (33%). |
| 06/02/2026 | Second vesting date for the restricted stock (33%). |
| 06/02/2027 | Final vesting date for the restricted stock (34%). |
| 06/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.